AURN001 Efficacy in Participants With Corneal Edema Secondary to Corneal Endothelial Dysfunction

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(12 sites)

United States

Investigational Site 2, Mesa, Arizona

Investigational Site 6, Little Rock, Arkansas

Investigational Site 9, Fort Collins, Colorado

Investigational Site 7, Atlanta, Georgia

Investigational Site 4, Kansas City, Missouri

Investigational Site 11, Leland, North Carolina

Investigational Site 5, Winston-Salem, North Carolina

Investigational Site 3, Cynwyd, Pennsylvania

Investigational Site 10, Plymouth Meeting, Pennsylvania

Investigational Site 12, Ladson, South Carolina

Investigational Site 8, San Antonio, Texas

Investigational Site 1, Spring, Texas